ZEOX (Zeo ScientifiX) Net Margin %: -5.62% (As of Apr. 2026)

What is Zeo ScientifiX Net Margin %?

Zeo ScientifiX ZEOX +2.94% 50 Net Margin % is -5.62% as of Apr. 2026. GuruFocus rates ZEOX with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Zeo ScientifiX ranks better than 54.17% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Zeo ScientifiX's Net Income for the three months ended in Apr. 2026 was $-0.15 Mil. Zeo ScientifiX's Revenue for the three months ended in Apr. 2026 was $2.58 Mil. Therefore, Zeo ScientifiX's net margin for the quarter that ended in Apr. 2026 was -5.62%.

The historical rank and industry rank for Zeo ScientifiX's Net Margin % or its related term are showing as below:

ZEOX' s Net Margin % Range Over the Past 10 Years
Min: -1574.04 Med: -190.61 Max: -55.59
Current: -55.59

ZEOX's Net Margin % is ranked better than
54.17% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs ZEOX: -55.59

Zeo ScientifiX (OTCPK:ZEOX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Zeo ScientifiX Net Margin % Related Terms

Zeo ScientifiX Net Margin % Historical Data

* Premium members only.

The historical data trend for Zeo ScientifiX's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeo ScientifiX Net Margin % Chart

Zeo ScientifiX Annual Data

Trend

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

Oct25

Net Margin %

Get a 7-Day Free Trial

-227.93

-137.07

-153.29

-101.84

-106.19

Zeo ScientifiX Quarterly Data
	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25	Apr25	Jul25	Oct25	Jan26	Apr26
Net Margin %	Get a 7-Day Free Trial															-121.06	-158.65	-49.27	-58.92	-5.62

ZEOX vs LNAI, GDTC, HOOK: Net Margin % Comparison

For the Biotechnology subindustry, Zeo ScientifiX's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zeo ScientifiX Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Net Margin % distribution charts can be found below:

* The bar in red indicates where Zeo ScientifiX's Net Margin % falls into.

Save Embed

50GF Score

Zeo ScientifiX Inc ZEOX

Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zeo ScientifiX Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Zeo ScientifiX's Net Margin for the fiscal year that ended in Oct. 2025 is calculated as

Net Margin	=	Net Income (A: Oct. 2025 )	/	Revenue (A: Oct. 2025 )
	=	-5.521	/	5.199
	=	-106.19 %

Zeo ScientifiX's Net Margin for the quarter that ended in Apr. 2026 is calculated as

Net Margin	=	Net Income (Q: Apr. 2026 )	/	Revenue (Q: Apr. 2026 )
	=	-0.145	/	2.581
	=	-5.62 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -5.62% mean?

Zeo ScientifiX (ZEOX) has a Net Margin % of -5.62% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #434 out of 947 companies in the Biotechnology industry, placing it in the top 45.8%.

Is Zeo ScientifiX's Net Margin % too high?

Zeo ScientifiX's current Net Margin % is -5.62%. Based on the distribution chart, Zeo ScientifiX ranks #434 out of 947 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Zeo ScientifiX's Net Margin % compare to LNAI and GDTC?

According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #434 out of 947 companies for Net Margin %. This puts Zeo ScientifiX in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Biotechnology company?

A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current Net Margin % is -5.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zeo ScientifiX stock overvalued right now?

Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current Net Margin % is -5.62%. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Net Margin % is -5.62% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeo ScientifiX (ZEOX) Overvalued in 2026?

Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued. The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67. GuruFocus considers Zeo ScientifiX to be Possible Value Trap.

Key valuation signals for ZEOX:

Net Margin %: -5.62%
GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zeo ScientifiX Business Description

Industry Healthcare Biotechnology

Comparable Companies LNAI GDTC HOOK CYCN SNGX HCWB MTVA INTI TOVX ICU VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address 3321 College Avenue, Suite 246, Davie, FL, USA, 33314

Website https://www.organicell.com

Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).

50GF Score

Get the complete analysis for ZEOX

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.75

Price

$2.67

GF Value

View ZEOX Analysis

See Net Margin % data for all stocks →